-
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
June 30, 2026 20:38 ET | Source: Mesoblast Limited NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a…
-
Regula Helps Uber Build a Nationwide Driver Verification Network in Poland
RESTON, Va., June 23, 2026 (GLOBE NEWSWIRE) — Regula is helping Uber bring advanced driver verification technologies to more cities across Poland. By expanding the use of Regula’s document authentication solutions nationwide, Uber is strengthening fraud prevention and adding an extra layer of high-assurance identity checks that goes beyond standard industry practices. As part of…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
